Aptahem signs clinical development collaboration LOI with Linköping University’s Folke Sjöberg for Apta-1 program
Bitget2026/09/25 14:03- Aptahem signed a non-binding clinical development collaboration LOI with Linköping University professor Folke Sjöberg on Sept. 25, 2026.
- Work targets a patient-study plan for Apta-1, focusing on severely burned patients where infections can progress to sepsis.
- Apta-1 has completed Phase 1 with no signs of serious adverse events; aim is to move toward Phase 2.
- Planning covers patient selection, endpoints, safety follow-up, recruitment feasibility, regulatory preparations, resource needs, financing model.
- Any study start remains subject to separate agreements, funding, necessary approvals.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Plasma is now live on the Pump.fun application

The US dollar marks its fourth consecutive week of gains
The US dollar is expected to rise for the fourth consecutive week, having gained over 3% this year. Anthropic surged by 17% on its first day of trading on Nasdaq, with overseas subscriptions reaching approximately 10 to 15 billion dollars, driving increased demand for foreign exchange. Additionally, the 10-year US Treasury yield remains above 5%, and the Federal Reserve's meeting minutes suggest another potential rate hike. Institutions predict the dollar's strength will continue until 2027.

DCTY dropped over 72% in 24 hours, with its current market capitalization at $3.8 million.

Citigroup's (C.US) European subsidiary made a trading accounting error, resulting in a $35 billion understatement of risk-weighted assets
It is reported that a Citi subsidiary underestimated risk assets by 35 billions USD.
